Encompass Health (NYSE:EHC) Reports Q3 In Line With Expectations But Stock Drops

Encompass Health reported steady Q3 results, meeting Wall Street expectations with $1.48 billion revenue (up 9.4% YoY) and $1.23 EPS (beating by 3%). The company expanded its network, opening more hospitals and adding beds, but annual revenue growth of 4.7% over the last five years is below sector average. Investors were disappointed by a 2.9% same-store sales growth and a 7% stock drop, despite meeting expectations. Analysts predict a slight slowdown in revenue growth but continued EPS growth. Encompass Health focuses on long-term growth and profitability, with investors awaiting future performance.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.